Xianju Pharmaceuticals: Obtained the registration certificate for Diqu-progesterone tablets.

Senju Pharmaceuticals Announcement: The company has recently received the Drug Registration Certificate for the approved and issued progesterone tablets from the National Medical Products Administration. This drug is classified as a Category 4 chemical drug, with a specification of 10mg, used for treating diseases caused by insufficient endogenous progesterone. The reference drug for progesterone tablets is the original imported progesterone tablet, with the brand name of "Duphaston", which has been marketed in countries such as the Netherlands, Germany, and Switzerland. Obtaining the registration certificate for this drug is beneficial for enriching the product line and enhancing market competitiveness.